Ana-Marta Silva

Employment

• Azores Pharmacovigilance Centre
  2024 - Present
• Faculty of Medicine - University of Porto Invited Assistant
  2023 - 2024
• School of Health Polytechnic of Porto Invited Assistant
  2022 - 2024
• University’s Institute of Health Sciences - CESPU Invited Assistant
  2020 - Present
• Faculty of Medicine University of Porto
  2013 - 2023

Education

• Faculty of Medicine, University of Porto PhD Student
  2015 - Present
• University’s Institute of Health Sciences - CESPU PharmD MSc
  2007 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (34)

• Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study
  Drug Safety 2025 DOI: 10.1007/s40264-024-01487-5
  +Save
• EPH3 Effectiveness of Additional Risk Minimization Measures When Using Baricitinib (RISK-BARI): Preliminary Analysis
  Value in Health 2024 DOI: 10.1016/j.jval.2024.10.1136
  +Save
• Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals
  Pharmacoepidemiology and Drug Safety 2024 DOI: 10.1002/pds.70057
  +Save
• [P236] ADR Reports in Portugal: Healthcare Professionals vs Consumers – 10 Years of Experience; 23rd ISoP Annual Meeting “Global Perspectives on Pharmacovigilance in the Digital Age and Advanced Therapeutics” 1–5 October 2024 Montreal, Canada
  Drug Safety 2024 DOI: 10.1007/s40264-024-01477-7
  +Save
• Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions – A cross-sectional study in six EU member states
  Vaccine 2024 DOI: 10.1016/j.vaccine.2023.12.065
  +Save
• ADR Reports in Portugal: Health Professionals vs Consumers - 10 Years Of Experience
  Farmacovigilância: envolver o cidadão. INFARMED, I.P. 2023
  +Save
• Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research
  The Journal of Clinical Pharmacology 2023 DOI: 10.1002/jcph.2195
  +Save
• Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey
  Journal of Community Health 2023 DOI: 10.1007/s10900-022-01168-3
  +Save
• Abstracts Presented at the 2022 International Pharmacoeconomics Forum
  Global Journal on Quality and Safety in Healthcare 2023 DOI: 10.36401/jqsh-23-x1
  +Save
• Dados De Segurança Do Mundo Real Em Mulheres Grávidas e/ou A Amamentar Em Portugal: Estudo Retrospetivo
  “Dia da Farmacovigilância” – INFARMED, I.P. 2022
  +Save